News from Lineberger Archives - Page 71 of 74

UNC Lineberger's Bhishamjit S. Chera, MD, and Gaorav Gupta, MD, PhD.

UNC Lineberger's Bhishamjit S. Chera, MD, will present preliminary findings at the 60th Annual Meeting of the American Society for Radiation Oncology on Tuesday from a study that evaluated a blood test for HPV-linked oropharyngeal squamous cell carcinoma, which is a cancer of the back of the throat. The findings demonstrated the test could be an effective and less costly alternative for monitoring for cancer recurrence after radiation treatment.

Daniel Reuland, MD, MPH, and colleagues published in JAMA Internal Medicine a review of data from 73 randomized clinical trials that tested different ways of increasing screening for colorectal cancer.

Daniel Reuland, MD, MPH, and colleagues published a review of data from 73 randomized clinical trials that tested different ways of increasing screening for colorectal cancer. Their analysis identified three approaches as being the most effective.

UNC Lineberger's Dirk Dittmer, PhD, Joel Parker, PhD, and Sara Selitsky, PhD.

UNC Lineberger’s Dirk Dittmer, PhD, Joel Parker, PhD, Sara Selitsky, PhD, and colleagues published a new study in the journal mSystems, an open access journal of the American Society for Microbiology. The study used data from The Cancer Genome Atlas project to explore whether Epstein-Barr virus is linked with additional cancer types beyond gastric cancer, nasopharyngeal carcinoma, and certain lymphomas, which have been convincingly linked to infection with the virus.

H. Shelton Earp, MD, and G. Greg Wang, PhD, have published a study that describe the role of androgen receptor variant 7 (AR-V7), an alternative form of the androgen receptor, that plays a key role in prostate cancer development.

In the journal Molecular Cell, researchers led by UNC Lineberger's G. Greg Wang, PhD, and H. Shelton Earp, MD, describe the role of a protein variant called androgen receptor variant 7 (AR-V7), which is an alternative form of the androgen receptor that plays a key role in prostate cancer development and treatment.

Stephanie Wheeler, PhD, MPH, and colleagues found that women with advanced breast cancer experience significant financial hardships associated with having the disease.

A study led by UNC Lineberger's Stephanie Wheeler, PhD, investigated the extent and severity of negative financial effects of cancer among women with breast cancer that has spread in the body. The preliminary results were presented at the American Society of Clinical Oncology’s Quality Care Symposium, held Sept. 28-29 in Phoenix.

UNC Lineberger's Paul A. Dayton, PhD, and his colleagues have been awarded a five-year, $3.2 million grant from the National Cancer Institute to investigate how to improve radiation treatment for pet dogs undergoing treatment for sarcoma.

UNC Lineberger's Lisa Carey, MD, was elected to ASCO board of directors

Included in the new investments by Susan G. Komen was $400,000 for UNC Lineberger’s Lisa Carey, MD, the physician-in-chief of the N.C. Cancer Hospital, Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, chief of the UNC School of Medicine Division of Hematology/Oncology, and a member of the Komen Scientific Advisory Board, for a study of HER2-positive breast cancer.

UNC School of Medicine, UNC Medical Center, and NC TraCS Institute awarded $50,000 to two teams of researchers led by UNC Lineberger's Jill Bates, PharmD, clinical oncology precision medicine pharmacist, along with Alison Stuebe, MD, and Ana Whitney, MS, to study pharmacogenomics and social determinants of maternal health.

UNC Lineberger's Jennifer Lund, PhD, was awarded a $732,000 grant from the Patient-Centered Outcomes Research Institute (PCORI). Lund serves as principal investigator for the project, “Enhancing hybrid study designs for comparative effectiveness research.”

Stephanie Wheeler, PhD, MPH, has published a study that found adherence to breast cancer medications may play a role in the disparity of outcomes between white and black women.

A study led by UNC Lineberger’s Stephanie Wheeler, PhD, found that black women were more likely than white women to report not taking endocrine therapy for breast cancer as prescribed, which could help explain why hormone-receptor positive breast cancer mortality is higher among black women.

Category: News from Lineberger

HPV blood test shows promise for tracking head and neck cancer after treatment

Scientists zero in on ways to boost colorectal cancer screening

UNC Lineberger researchers published in mSystems

Insights about prostate cancer resistance could lead to treatment strategies

Metastatic breast cancer patients report high level of financial impact

Study focused on improving radiation treatment for cancers in pet dogs

Susan G. Komen awards UNC Lineberger $1.1M for breast cancer research

UNC researchers awarded emerging challenges grants

Lund leads PCORI-funded project to improve hybrid study designs

Black women more likely to report not taking breast cancer medication as prescribed